ArticleBMC rheumatology2024

Janus kinase inhibitors vs. abatacept about safety and efficacy for patients with rheumatoid arthritis-associated interstitial lung disease: a retrospective nested case-control study.

Atsuko Tsujii et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.